General
Preferred name
GLUCONOLACTONE
Synonyms
D-(+)-Glucono-1,5-lactone ()
Gluconic acid lactone ()
Delta-Gluconolactone ()
Glucono delta-lactone ()
D-glucono-1,5-lactone ()
.delta.-d-gluconolactone ()
Glucono-delta-lactone ()
INS-575 ()
INS NO.575 ()
D-gluconic acid .delta.-lactone ()
Lysactone ()
E-575 ()
NSC-34393 ()
Fujiglucon ()
D-gluconic acid delta-lactone ()
E575 ()
Riken lactone ()
Glucono .delta. lactone ()
Glucono .delta.-lactone ()
NSC-758238 ()
P&D ID
PD006000
CAS
90-80-2
4253-68-3
1335-57-5
Tags
natural product
drug
available
Approved by
FDA
First approval
1990
Drug Status
experimental
approved
Drug indication
Discovery agent
Chelating Agent
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
11
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
TargetMol Bioactive Compound Library
External IDs
61
Properties
(calculated by RDKit )
Molecular Weight
178.05
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
4
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
0
cLogP
-3.01
TPSA
107.22
Fraction CSP3
0.83
Chiral centers
4.0
Largest ring
6.0
QED
0.32
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Immunology/Inflammation
Metabolic Enzyme/Protease
NF-κB
Target
LPH
Endogenous Metabolite
Reactive Oxygen Species
Source data